We are live on ! Find out more
SLC

Second Line Capital Portfolio holdings

AUM $528M
1-Year Est. Return 16.68%
This Fund
S&P 500
This Quarter Est. Return
+2.66%
1 Year Est. Return
+16.68%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$371M
AUM Growth
+$3.99M
Cap. Flow
+$3.98M
Cap. Flow %
1.07%
Top 10 Hldgs %
57.72%
Holding
148
New
12
Increased
56
Reduced
51
Closed
17

Top Buys

Rank Stock Value
1
NTLA icon
Intellia Therapeutics
NTLA
+$2.05M
2
HD icon
Home Depot
HD
+$1.73M
3
NVDA icon
NVIDIA
NVDA
+$1.73M
4
DRSK icon
Aptus Defined Risk ETF
DRSK
+$1.17M
5
IDUB icon
Aptus International Enhanced Yield ETF
IDUB
+$1.02M

Top Sells

Rank Stock Value
1
ON icon
ON Semiconductor
ON
+$2.33M
2
SOFI icon
SoFi Technologies
SOFI
+$1.92M
3
AVGO icon
Broadcom
AVGO
+$1.88M
4
APP icon
Applovin
APP
+$1.64M
5
BBBY
Bed Bath & Beyond
BBBY
+$1.52M

Sector Composition

Rank Sector Weight
1 Technology 8.77%
2 Financials 5.24%
3 Communication Services 4.75%
4 Healthcare 3.89%
5 Energy 3.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSLA icon
26
Tesla
TSLA
$1.26T
$3.19M 0.86%
7,888
-32
-0.4% -$10.3K
CPRT icon
27
Copart
CPRT
$25.2B
$3.01M 0.81%
52,524
-95
-0.2% -$5.41K
BR icon
28
Broadridge
BR
$16.7B
$3M 0.81%
13,227
+554
+4% +$124K
PGR icon
29
Progressive
PGR
$120B
$2.99M 0.81%
12,493
+367
+3% +$92.4K
UNH icon
30
UnitedHealth
UNH
$385B
$2.96M 0.8%
5,849
+812
+16% +$461K
PWR icon
31
Quanta Services
PWR
$98.1B
$2.94M 0.79%
9,317
-416
-4% -$134K
OCUL icon
32
Ocular Therapeutix
OCUL
$1.89B
$2.9M 0.78%
340,098
+77,288
+29% +$754K
CHE icon
33
Chemed
CHE
$6.68B
$2.84M 0.76%
5,353
+756
+16% +$426K
ROP icon
34
Roper Technologies
ROP
$35.1B
$2.83M 0.76%
5,442
+404
+8% +$222K
FANG icon
35
Diamondback Energy
FANG
$57.8B
$2.81M 0.76%
17,161
+3,493
+26% +$616K
AMT icon
36
American Tower
AMT
$76.7B
$2.69M 0.73%
14,542
+2,686
+23% +$557K
AMD icon
37
Advanced Micro Devices
AMD
$880B
$2.58M 0.7%
21,357
+3,519
+20% +$506K
VOO icon
38
Vanguard S&P 500 ETF
VOO
$967B
$2.25M 0.61%
4,168
-90
-2% -$48.7K
GCT icon
39
GigaCloud Technology
GCT
$1.33B
$2.23M 0.6%
120,332
+17,852
+17% +$413K
AVGO icon
40
Broadcom
AVGO
$1.87T
$2.16M 0.58%
9,313
-10,163
-52% -$1.88M
VKTX icon
41
Viking Therapeutics
VKTX
$4.11B
$1.99M 0.54%
49,511
+11,393
+30% +$650K
NTLA icon
42
Intellia Therapeutics
NTLA
$1.55B
$1.53M 0.41%
+131,122
New +$2.05M
ARCC icon
43
Ares Capital
ARCC
$13.4B
$1.51M 0.41%
69,126
+15,002
+28% +$324K
SCD
44
LMP Capital and Income Fund
SCD
$353M
$1.3M 0.35%
75,600
+1,200
+2% +$20.7K
LOW icon
45
Lowe's Companies
LOW
$113B
$1.18M 0.32%
4,793
+44
+0.9% +$11.8K
BRK.B icon
46
Berkshire Hathaway Class B
BRK.B
$1.06T
$1M 0.27%
2,213
-75
-3% -$34.6K
SO icon
47
Southern Company
SO
$109B
$986K 0.27%
11,973
+1,348
+13% +$118K
QQQ icon
48
Invesco QQQ Trust
QQQ
$460B
$954K 0.26%
1,865
-11
-0.6% -$5.56K
SPMD icon
49
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.2B
$952K 0.26%
17,407
-1,602
-8% -$90.2K
T icon
50
AT&T
T
$157B
$883K 0.24%
38,799
-6,081
-14% -$137K
1
2
3 4 5

Similar funds

OMC
Overbrook Management Corp New York $529M AUM 31.5% 1-Year Est. Return
OC
Oakmont Corp Los Angeles, California $526M AUM 7.52% 1-Year Est. Return
TM
Taproot Management New York $530M AUM
DSC
Duncker Streett & Co St. Louis, Missouri $526M AUM 22.2% 1-Year Est. Return
EPA
Element Pointe Advisors Miami, Florida $530M AUM 16.87% 1-Year Est. Return
IA
Insight Advisors Newtown, Pennsylvania $525M AUM 15.94% 1-Year Est. Return
UFF
USA Financial Formulas Ada, Michigan $531M AUM 28.6% 1-Year Est. Return
FWM
Fonville Wealth Management Richmond, Virginia $525M AUM 16.61% 1-Year Est. Return

Second Line Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Second Line Capital held 148 positions worth $371M, up 1.1% from $367M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Second Line Capital's Q4 2024 filing shows 12 new, 56 increased, 51 reduced and 17 closed positions. Its largest new stake was Intellia Therapeutics: 131,122 shares worth $1.53M. The largest sale was ON Semiconductor, an estimated $2.33M.

By sector, the portfolio is most concentrated in Technology at 8.8% of assets, down from 9.2% a quarter earlier, followed by Financials and Communication Services.

  • Second Line Capital's largest Q4 2024 buy was Intellia Therapeutics: 131,122 shares worth $1.53M.
  • Second Line Capital added most to Home Depot in Q4 2024, an estimated $1.73M increase.
  • Second Line Capital's biggest Q4 2024 reduction was Broadcom, cutting an estimated $1.88M.
  • Second Line Capital fully exited ON Semiconductor in Q4 2024, selling an estimated $2.33M.
  • Second Line Capital's ten largest holdings make up 58% of its $371M portfolio in Q4 2024.
  • Second Line Capital opened 12 new positions and closed 17 in Q4 2024.
  • Second Line Capital's portfolio value rose 1.1% quarter-over-quarter to $371M.

Based on Second Line Capital's 13F filing for Q4 2024, filed 14 Feb 2025.